Leg Ulcer

3
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ConvaTec
ConvaTecNJ - Bridgewater
3 programs
1
1
1
AQUACEL® AgPhase 41 trial
AQUACEL®Phase 31 trial
EASH dressingPhase 21 trial
Active Trials
NCT01497210CompletedEst. Apr 2012
NCT01591434CompletedEst. Sep 2012
NCT01084577CompletedEst. Jan 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ConvaTecAQUACEL® Ag
ConvaTecAQUACEL®
ConvaTecEASH dressing

Clinical Trials (3)

NCT01084577ConvaTecAQUACEL® Ag

AQUACEL® Ag Dressing and Urgotul® Silver Dressing on Healing of Chronic Venous Leg Ulcers

Start: Jan 2010Est. completion: Jan 2011
Phase 4Completed
NCT01591434ConvaTecAQUACEL®

Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers

Start: May 2012Est. completion: Sep 2012
Phase 3Completed
NCT01497210ConvaTecEASH dressing

EASH Dressing on Chronic Venous Leg Ulcers

Start: Nov 2011Est. completion: Apr 2012
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space